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Influenza Vaccinations: A Leadership
Approach
Christine Ann Meister, BS
ABSTRACT
Each year thousands of individuals in the United States are diagnosed with cases of seasonal influenza (flu) and the recent
pandemic strain of H1N1 influenza. Complications of the flu can lead to serious health issues resulting in hospitalization and
even death. Vaccination for seasonal flu and H1N1 can decrease the number of cases of the flu, thus decreasing the number of
complications resulting from infection. Unfortunately, a large percentage of the population chooses not to get vaccinated every
year for the seasonal flu because they do not trust vaccine safety and effectiveness. To gain the public’s trust and increase the
number of influenza inoculations, the Centers for Disease Control and Prevention (CDC) and state health departments should
incorporate John Kotter’s eight-stage plan for leadership change. Kotter’s plan helps groups create goals that eventually lead to
a cultural change. Goals of educating both the general population and individuals at risk of complications from the flu will
lead to an increase in trust and eventual reduction of influenza complications and deaths.
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Background
Every year tens of thousands of people get sick
from the flu. The Centers for Disease Control and
Prevention (CDC) estimate that from 1976 to 2006,
between 3,000 and 49,000 deaths were caused by flu
related illnesses (CDC, 2011a). The incidence of flu
and incidence of complications from the virus can be
reduced and even prevented by increasing the
number of people who are vaccinated each year
against seasonal and H1N1 influenza. Unfortunately,
a large portion of the population does not get
vaccinated. This paper addresses the main reasons
why at-risk populations choose not to get vaccinated
for the flu and provides an action plan for increasing
the number of people who are vaccinated each year.
Significance of Problem
The CDC (2011b) estimates that between April
2009 and April 2010, during the pandemic H1N1 flu
season, between 43 million and 89 million cases of
H1N1 were reported in the United States, resulting
in 8,870-18,300 deaths. Between October 3, 2010
and May 21, 2011, the World Health Organization
(WHO) and National Respiratory and Enteric Virus
Surveillance System (NREVSS) recorded 40,282
cases of influenza A (including both H3N2 and
H1N1 viruses) and 13,944 cases of influenza B
viruses. These numbers may be underestimated,
however, because not all cases during the flu season
were reported and tested. Although that season was
less severe than the 2009-2010 season, it was more
severe than the 2008-2009 flu season (CDC, 2011b).
Everyone aged six months and older should get
vaccinated, especially those who are at risk for
severe complications for the flu and those who work
or live in close proximity to those at risk (CDC,
2011c). Vaccine campaigns are run by both the CDC
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and state health departments; however vaccination
turnouts for the seasonal flu are not high. In the
June 10, 2011 Morbidity and Mortality Weekly Report
(MMWR), the CDC estimated that nationwide about
49% of children between six months and 17 years of
age were vaccinated during the 2010-2011 flu
season, about 6.7% higher than the previous flu
season. About 30.2% of adults between 18 and 49
years of age, 45.6% of adults between 50 and 64
years of age, and 68.6% of adults aged 65 and older
were vaccinated during the 2010-2011 season.
According to the CDC (2011c) 48.4% of at-risk
adults with a medical condition that increases their
chance for complications caused by influenza were
inoculated for the seasonal flu last year.
If we are to increase the number of flu vaccine
inoculations each season, an action plan needs to be
put in place. A movement structured around a
strong leadership process may help gain the public’s
trust in the CDC, state health departments and the
safety of vaccination techniques.
Factors Related to or Affecting the Problem
Many of the reasons why the general population
does not get vaccinated revolve around the idea that
people cannot trust the CDC or that vaccinations are
a money-making ploy for the drug companies that
create them (Swine Flu Information, 2011). Ramsey
and Marczinski (2011) found that college students
who chose not to get vaccinated for H1N1, did so
because they believed that the vaccine would not
work, that the vaccine had not been tested enough,
and because they were worried about both serious
and minor side effects. Pregnant women are also
identified as an at-risk group for complications due
to H1N1 influenza. The most common reasons for
pregnant women to choose not to get vaccinated for
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the H1N1 and seasonal influenza was because they
had not been vaccinated in the past, because they
were afraid for the health of their babies and because
they were concerned about their own health
(Ahluwalia, Singleton, Jamieson, Rasmussen and
Harrison, 2011).
The choice not to get vaccinated is an important
decision in personal autonomy. However, the
public’s mistrust of the safety of vaccines is
unfounded. Vaccines are rigorously tested by drug
companies before the FDA can approve of them. The
CDC and U.S. Vaccine Adverse Event Reporting
System (VEARS) reported that during the 2010-11
flu season, an estimated 163 million doses of
influenza vaccine were administered in the U.S. As
of December 14, 2010, VAERS received 6845
reports of adverse affects to the vaccine. Of those
reports, 415 were considered serious side effects.
Included among those 415 reports were 18 reports
of deaths and 51 reports of Guillian Barré Syndrome
(GBS). It had not been confirmed, however, that
those 18 deaths and GBS reports were a direct result
of the influenza vaccine (VEARS, 2011).
It is important that vaccine safety concerns are
not misrepresented in the media. The CDC, state
health departments and the media need to trust that
the public will recognize safety concerns and still
and will be able to make the appropriate decision
regarding their heath and the safety of others. The
risks should be discussed in a clear and informative
manner to protect personal autonomy. At the same
time, the public needs to be educated about the
overall benefits vaccinations can have for both
individuals and the nation as a whole.
Implications for Leadership
John Kotter outlines an eight-stage process of
leadership in his book Leading Change. His outline
begins with establishing a need for change and ends
with ensuring that the change is ingrained into the
culture of the population. Incorporating Kotter’s
leadership action plan into vaccine campaigns may
help to increase the number of influenza vaccine
inoculations and thus decrease the number of flurelated illnesses and deaths each year.
Step 1: Establish a Sense of Urgency
The first step in Kotter’s leadership action plan
is to emphasize the need for change. Sources of
complacency must be identified and eliminated for
the change to begin.
“With
complacency
high,
transformations usually go nowhere
because few people are even
interested in working on the change
problem. With urgency low, it’s
difficult to put together a group with
enough power and credibility to
guide the effort or to convince key
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individuals to spend the time
necessary to create and communicate
a change vision” (Kotter, 1996).
Kotter explains that sources of complacency include
the absence of a major visible crisis, low performance
standards by individuals, human nature, and capacity
for denial.
Applying these ideas to the influenza vaccine
issue, the sources of complacency are the mistrust of
vaccine safety, belief that vaccines are ineffective and
thus will not help the issue, and the belief that the
individual cannot make a difference in increasing the
number of vaccine inoculations.
To remove and/or minimize the sources of
complacency, the public needs to be made aware of
the positive and negative sides of receiving a vaccine.
Campaigns need to respect the intelligence of the
individual while emphasizing the importance of
vaccination for society as a whole, the family unit,
and the individual.
Step 2: Create the Guiding Coalition
The second step in the Kotter’s leadership
action plan is to select a group to lead the campaign
for change. This group must be able to adapt to the
ever-changing market, must be large enough to have
political power, must be experts in the field while
still representing various points of view, and must
have enough credibility to be taken seriously
(Kotter, 1996).
State health departments may be the best option
to lead the influenza vaccine campaign. The CDC
would have the most political clout, but state health
organizations have the ability to design their
programs for the needs of their own state. State
health departments can create educational programs
within schools, as well as within insurance
companies and other health-related groups. State
departments may be able to reach the public using
local media in ways that may be difficult for a federal
organization like the CDC.
Step 3: Develop a Vision and Strategy
After designating a leadership group to guide
the change, goals and visions for the future must be
established. “Vision refers to a picture of the future
with some implicit or explicit commentary on why
people should strive to create that future” (Kotter,
1996). Kotter explains that these goals should not be
authoritarian in nature and that they should not
micromanage the groups and individuals within the
overall corporation/population. Instead, the strategy
should work to clarify the goals of the campaign and
should motivate those affected by the change.
Visions should be imaginable, desirable, feasible,
focused, flexible, and easily communicable (Kotter,
1996).
The visions for an influenza vaccine campaign
should be geared towards those at greatest risk for
complications from the flu and then should expand
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to include the general population. Those at greater
risk for complications are young children, adults 65
and older, pregnant women as well as people with
certain chronic illnesses such as asthma, heart
disease and weakened immune systems (CDC,
2011a). The goals should include not only increasing
the number of vaccinations, but also educating the
population and encouraging trust in the state health
departments, the CDC, and vaccine companies.
Steps 4 and 5: Communicating the Change Vision and
Empowering Broad-based Action
The next steps in the leadership process are
advertising and carrying out the campaign’s visions.
Kotter (1996) is clear that when trying to achieve
the group’s vision, the leadership coalition should
not limit the capabilities of the population and
should not underestimate the power of the
individual. The campaign should communicate its
goals in a simple but effective way using multiple
techniques. The leaders should teach by example.
Also, like any good persuasive argument, the
campaign should acknowledge counter arguments
and should respectfully refute their statements.
Part of empowering broad-based action is to
identify other sources of complacency and barriers
that may have not been evident while organizing the
leadership change (Kotter, 1996). By providing
training to individuals outside of the guiding
coalition while still maintaining the essential
structure of the campaign, individuals within the
target population can take actions on their own to
help achieve the organization’s goals.
Communicating the vision for increasing the
number of influenza vaccinations should be
respectful of individual autonomy and should
effectively communicate both the benefits and risks
of receiving a flu shot. Flu shot campaigns should
include all types of media and there should be
opportunities for the public to discuss their concerns
and provide feedback. Effective communication
between the guiding coalition and the target
population will lead to an increase in autonomy,
allowing individuals to make their own informed and
educated decisions. Individuals within the target
population will become the informants, possibly
leading to a snowball effect of encouraging others to
get vaccines.
Steps 6 and 7: Generate Short-term Wins and
Consolidate Gains to Produce More Change
Short-term wins are necessary to evaluate the
effectiveness of the leadership change. According to
Kotter (1996), a good short term win is visible,
unambiguous and clearly related to the change
effort, meaning that the result is clear, easily
distinguished and is a natural step towards achieving
the overall vision. It is also important that the
guiding coalition does not lose motivation after the
first few goals are achieved. “Whenever you let up
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before the job is done, critical momentum can be lost
and regression may follow” (Kotter, 1996). Shortterm gains should be recognized and the group
needs to be immediately motivated to work towards
the next goal.
Part of reducing momentum-loss is to recognize
interdependencies within the guiding coalition and
to eliminate those that are unnecessary (Kotter,
1996). Codependency can hold groups back by
attempting to serve more than one agenda. By
eliminating extraneous and outside factors,
campaigns can continue to grow to their full
potential.
Short-term goals in vaccine campaigns can be
measured by the increase in numbers of vaccinated
individuals and by cross-sectional studies on beliefs
about vaccine importance, effectiveness and safety,
as well as the trust in government vaccine
campaigns. Once goals are achieved, their results
should be distributed to the public, encouraging
more people to take action.
By breaking up interdependencies within
influenza vaccine campaigns, individual groups may
be able to gain more ground and reach separate
populations. For example, health insurance
companies working with multiple doctors’ offices to
campaign for increasing vaccine inoculations could
work with each doctors’ office separately to begin
campaigning on their own. Each doctors’ office
would be better able to target their campaign
towards the individuals they are serving rather than
the larger population of multiple offices.
Step 8: Anchor New Approaches in Culture
The final step in Kotter’s approach to leadership
change is to ingrain the goals of the organization
into the goals of the culture. “Until changed
practices attain a new equilibrium and have been
driven into the culture, they can be very fragile”
(Kotter, 1996). Inconsistencies between the modern
culture and the goals of the campaign should be
confronted and addressed; otherwise the changes
made by the organization will be defaulted back to
attitudes present before the campaign began.
There is an inconsistency between goals of
vaccine campaigns and the values of society. This
inconsistency mainly revolves around the
trust/mistrust of government safety tests for
influenza vaccines and the necessity of getting a
vaccine in the first place. To gain the public’s trust,
the vaccine campaigns need to be educational. The
guiding coalitions need to trust the public to make
informed decisions regarding their autonomy based
on the education the coalition provides to them.
Vaccine campaigns need to explain the effectiveness
of safety tests and vaccine statistics to gain the
public’s trust. If the goals of the campaign are going
to be ingrained in society, society has to trust that
the goals are both reasonable and honest.
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Conclusion
To increase the amount of influenza
vaccinations amongst populations in the U.S., the
CDC and state health departments should
incorporate John Kotter’s eight-step process of
leadership change. By developing short-term and
long-term goals, health departments can continue to
gain momentum in educating the public about the
effectiveness and necessity of influenza inoculation.
Eventually the goals of the health department will
be incorporated into the mainstream goals of society,
leading to a permanent health change.
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